Metropolis Healthcare Limited has informed the Exchange regarding Outcome of Postal Ballot. Further, the company has submitted the Exchange a copy of Srutinizers report
METROPOLIS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Metropolis Healthcare has completed a Postal Ballot process, and shareholders have approved three resolutions with overwhelming majority. Mr. Surendran Chemmenkotil (DIN: 10818890) has been appointed as the new Managing Director of the company, receiving 96.13% votes in favour (approximately 4.52 crore shares out of 4.70 crore polled). Additionally, Ms. Purvi Sheth and Mr. Rehan Khan have been appointed as Non-Executive Independent Directors, with 99.57% and 99.99% approval respectively. The voting was conducted via remote e-voting between May 16 and June 14, 2025, with about 90.74% of total shares participating. Promoters voted 100% in favour of all resolutions, while public institutions showed strong support (around 91.59% to 100% in favour across resolutions).
The appointment of a new Managing Director signals a leadership transition at Metropolis Healthcare, which could shape the company's strategic direction going forward. The strong shareholder approval (over 96%) reflects broad confidence in the new leadership and governance changes. Investors will likely monitor the new MD's strategy and execution closely.